https://www.selleckchem.com/pr....oducts/-epicatechin.
To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019. This study used the National Survey of Children's Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (
<i>n</i>=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD. The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with